Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease

Figure 1

Pentraxin 3 concentrations (ng/mL) in the plasma of NAFLD patients with fibrosis (), NAFLD patients without fibrosis (), and healthy controls (). for control versus NAFLD without fibrosis, for control versus NAFLD with fibrosis, and for NAFLD with fibrosis versus NAFLD without fibrosis. Pentraxin 3 levels were less than 2 ng/mL (cutoff) in both NAFLD patients without fibrosis and control subjects.